Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuromodulatory effects of anti-diabetes medications: A mechanistic review
Habib Yaribeygi, Milad Ashrafizadeh, Neil C. Henney, et al.
Pharmacological Research (2019) Vol. 152, pp. 104611-104611
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation
Maliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112563-112563
Open Access | Times Cited: 213
Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
Richard J. Miron, Nathan E. Estrin, Anton Sculean, et al.
Periodontology 2000 (2024) Vol. 94, Iss. 1, pp. 257-414
Open Access | Times Cited: 15
Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review
Tahiana Ramaholimihaso, Fayçal Bouazzaoui, Arthur Kaladjian
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 81
Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications
Milad Ashrafizadeh, Alan Prem Kumar, Amir Reza Aref, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1229-1253
Open Access | Times Cited: 58
Diabetes, antidiabetic medications and risk of depression – A population-based cohort and nested case-control study
Ida Kim Wium‐Andersen, Merete Osler, Martin Balslev Jørgensen, et al.
Psychoneuroendocrinology (2022) Vol. 140, pp. 105715-105715
Open Access | Times Cited: 47
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Life Sciences (2022) Vol. 300, pp. 120561-120561
Closed Access | Times Cited: 45
Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
Zheng Shen, Zhengyang Li, Mengting Yu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114206-114206
Open Access | Times Cited: 30
GLP-1 mimetics and cognition
Habib Yaribeygi, Ali Rashidy‐Pour, Stephen L. Atkin, et al.
Life Sciences (2020) Vol. 264, pp. 118645-118645
Closed Access | Times Cited: 61
Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease
Vladimirs Piļipenko, Karīna Narbute, Jolanta Pupure, et al.
European Journal of Pharmacology (2020) Vol. 881, pp. 173290-173290
Closed Access | Times Cited: 52
Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art.
Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, et al.
PubMed (2023) Vol. 22, pp. 53-66
Closed Access | Times Cited: 17
Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus
Ivan M. Veselov, Daria V. Vinogradova, Andrey V. Maltsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14450-14450
Open Access | Times Cited: 16
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access
Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet
Sakshi Misra, Prabha Rajput, Amandeep Kaur
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Shahla Rezaei, Reza Tabrizi, Peyman Nowrouzi‐Sohrabi, et al.
Canadian Journal of Gastroenterology and Hepatology (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 39
Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes
Gabriela Dumitrița Stanciu, Răzvan Nicolae Rusu, Veronica Bild, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 576-576
Open Access | Times Cited: 33
Impacts of Sodium/Glucose Cotransporter-2 Inhibitors on Circulating Uric Acid Concentrations: A Systematic Review and Meta-Analysis
Abolfazl Akbari, Mahdi Rafiee, Thozhukat Sathyapalan, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 26
Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu
Habib Yaribeygi, Mina Maleki, Željko Reiner, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6544-6544
Open Access | Times Cited: 26
Occurrence, synthesis and biological activity of 2-(2-phenyethyl)chromones
Meiyan Fan, Wei Yang, Min He, et al.
European Journal of Medicinal Chemistry (2022) Vol. 237, pp. 114397-114397
Closed Access | Times Cited: 24
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats
Habib Yaribeygi, Mohammad Amin Hemmati, Fatemeh Sokouti Nasimi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3815-3815
Open Access | Times Cited: 14
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
Bruno Dutra Arbo, Lúcia Emanueli Schimith, Michele Goulart dos Santos, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174800-174800
Open Access | Times Cited: 19
The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis
Sara Najafi, Milad Bahrami, Alexandra E. Butler, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 8, pp. 3627-3637
Open Access | Times Cited: 18
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
Wenjun Su, Ting Hu, Chun‐Lei Jiang
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 810-842
Closed Access | Times Cited: 11
Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
Young Sup Woo, Hyun Kook Lim, Sheng‐Min Wang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6969-6969
Open Access | Times Cited: 28
The Impact of Incretin-Based Medications on Lipid Metabolism
Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 20
Quassia amara bioactive compounds as a Novel DPP-IV inhibitor: an in-silico study
Ezekiel A. Olugbogi, Damilola S. Bodun, Shola D. Omoseeye, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2022) Vol. 46, Iss. 1
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top